Amir Kalali

Director; Science and Technology Committee Member; Co-Chair Nominating and Corporate Governance Committee at atai Life Sciences

About

Amir Kalali is a physician-scientist working at the intersection of life sciences and technology, serving as a board director and advisor to private and public companies, universities, and investment groups. He is a Professor of Psychiatry at the University of California San Diego, Editor of Innovations in Clinical Neuroscience, and Lead Editor of Essential CNS Drug Development, with over 250 peer-reviewed publications. He previously led the Neuroscience Center of Excellence at Quintiles (now IQVIA) for nearly 20 years and co-chairs the Decentralized Trials and Research Alliance while chairing the CNS Summit.